REVIEW article
Front. Med.
Sec. Ophthalmology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1582284
This article is part of the Research TopicReviews in: Ophthalmology 2024View all 8 articles
Non-surgical treatment of strabismus in children: a review of recent advances
Provisionally accepted
- Xiaolan People's Hospital of Zhongshan, Zhongshan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Pediatric strabismus is a progressive condition that, in the early stages, presents as either esotropia or intermittent or constant exotropia when both eyes focus on the same target. If not promptly addressed, the child's ocular accommodative convergence and fusion abilities will gradually weaken, ultimately affecting visual function and causing various inconveniences in daily life and learning. For children with mild strabismus, those who are young, have poor cooperation, or are awaiting surgery for a long time, non-surgical treatment is a good option. It offers high safety, ease of use, and has certain effects in alleviating strabismus symptoms and improving visual function. However, there are multiple non-surgical treatment options, and currently, clinical practice lacks clear consensus on which approach is best. The choice and implementation of treatment methods still need to be determined based on the specific situation, such as the child's age and type of strabismus. In recent years, with the deepening of ophthalmological research, non-surgical treatment methods have been enriched, including a combination of visual training, occlusion therapy, and corrective glasses, which have shown certain clinical effects. This article will review the non-surgical treatment options for pediatric strabismus, explore current research progress, and discuss future development directions.
Keywords: Strabismus, Children, non-surgical treatment, Corrective Glasses, Botulinum Toxin
Received: 24 Feb 2025; Accepted: 16 Jun 2025.
Copyright: © 2025 Huang, Zhong, Quan and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mingwen Zhang, Xiaolan People's Hospital of Zhongshan, Zhongshan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.